Enhancement of trypsin-induced contraction by in vivo treatment with 17β-estradiol and progesterone in rat myometrium

Murasaki Aman, Katsuya Hirano, Junji Nishimura, Hitoo Nakano, Hideo Kanaide

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We have previously reported that the contractile response to thrombin and trypsin was enhanced in the pregnant rat myometrium. We herein determined whether or not sex hormones contribute to this enhancement and the expression of protease-activated receptors (PARs). The nonpregnant rats received daily injections of either 17β-estradiol or progesterone, and then the contractile response of the myometrium was examined ex vivo. Treatment with either 17β-estradiol or progesterone had almost no significant enhancing effect on the high K +- or oxytocin-induced contraction. On the other hand, both 17β-estradiol and progesterone dose-dependently enhanced the contractile response to trypsin. A maximal enhancement was obtained at 25 and 40 mg kg weight -1 day -1 for 17β-estradiol and progesterone, respectively. The extent of the enhancement of the trypsin-induced contraction seen in the sex hormone-treated rats in the present study was comparable to that reported in the pregnant rats. However, the contractile response to thrombin and PAR1/PAR2-AP, SFLLRNP was not enhanced either by progesterone or 17β-estradiol. PAR2-AP and PAR4-AP failed to induce contraction under any conditions. PAR1 mRNA was scarcely detected in the control myometrium by an RT-PCR analysis, while it slightly increased only in the progesterone-treated rats. Neither PAR2 nor PAR4 mRNA was detected. We thus conclude that the responsiveness to trypsin, but not thrombin, is controlled by sex hormones. A novel type of receptor, other than PAR1, PAR2 or PAR4, is suggested to mediate the trypsin-induced contraction as in the case of the pregnant rat myometrium.

Original languageEnglish
Pages (from-to)425-434
Number of pages10
JournalBritish Journal of Pharmacology
Volume146
Issue number3
DOIs
Publication statusPublished - Oct 1 2005

Fingerprint

Myometrium
Trypsin
Progesterone
Estradiol
Gonadal Steroid Hormones
Thrombin
thrombin receptor peptide SFLLRNP
Therapeutics
Proteinase-Activated Receptors
PAR-1 Receptor
Messenger RNA
Oxytocin
Weights and Measures
Polymerase Chain Reaction
Injections

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Enhancement of trypsin-induced contraction by in vivo treatment with 17β-estradiol and progesterone in rat myometrium. / Aman, Murasaki; Hirano, Katsuya; Nishimura, Junji; Nakano, Hitoo; Kanaide, Hideo.

In: British Journal of Pharmacology, Vol. 146, No. 3, 01.10.2005, p. 425-434.

Research output: Contribution to journalArticle

Aman, Murasaki ; Hirano, Katsuya ; Nishimura, Junji ; Nakano, Hitoo ; Kanaide, Hideo. / Enhancement of trypsin-induced contraction by in vivo treatment with 17β-estradiol and progesterone in rat myometrium. In: British Journal of Pharmacology. 2005 ; Vol. 146, No. 3. pp. 425-434.
@article{e0fc3b567f8143b89c2f25a8f46c2ed6,
title = "Enhancement of trypsin-induced contraction by in vivo treatment with 17β-estradiol and progesterone in rat myometrium",
abstract = "We have previously reported that the contractile response to thrombin and trypsin was enhanced in the pregnant rat myometrium. We herein determined whether or not sex hormones contribute to this enhancement and the expression of protease-activated receptors (PARs). The nonpregnant rats received daily injections of either 17β-estradiol or progesterone, and then the contractile response of the myometrium was examined ex vivo. Treatment with either 17β-estradiol or progesterone had almost no significant enhancing effect on the high K +- or oxytocin-induced contraction. On the other hand, both 17β-estradiol and progesterone dose-dependently enhanced the contractile response to trypsin. A maximal enhancement was obtained at 25 and 40 mg kg weight -1 day -1 for 17β-estradiol and progesterone, respectively. The extent of the enhancement of the trypsin-induced contraction seen in the sex hormone-treated rats in the present study was comparable to that reported in the pregnant rats. However, the contractile response to thrombin and PAR1/PAR2-AP, SFLLRNP was not enhanced either by progesterone or 17β-estradiol. PAR2-AP and PAR4-AP failed to induce contraction under any conditions. PAR1 mRNA was scarcely detected in the control myometrium by an RT-PCR analysis, while it slightly increased only in the progesterone-treated rats. Neither PAR2 nor PAR4 mRNA was detected. We thus conclude that the responsiveness to trypsin, but not thrombin, is controlled by sex hormones. A novel type of receptor, other than PAR1, PAR2 or PAR4, is suggested to mediate the trypsin-induced contraction as in the case of the pregnant rat myometrium.",
author = "Murasaki Aman and Katsuya Hirano and Junji Nishimura and Hitoo Nakano and Hideo Kanaide",
year = "2005",
month = "10",
day = "1",
doi = "10.1038/sj.bjp.0706345",
language = "English",
volume = "146",
pages = "425--434",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Enhancement of trypsin-induced contraction by in vivo treatment with 17β-estradiol and progesterone in rat myometrium

AU - Aman, Murasaki

AU - Hirano, Katsuya

AU - Nishimura, Junji

AU - Nakano, Hitoo

AU - Kanaide, Hideo

PY - 2005/10/1

Y1 - 2005/10/1

N2 - We have previously reported that the contractile response to thrombin and trypsin was enhanced in the pregnant rat myometrium. We herein determined whether or not sex hormones contribute to this enhancement and the expression of protease-activated receptors (PARs). The nonpregnant rats received daily injections of either 17β-estradiol or progesterone, and then the contractile response of the myometrium was examined ex vivo. Treatment with either 17β-estradiol or progesterone had almost no significant enhancing effect on the high K +- or oxytocin-induced contraction. On the other hand, both 17β-estradiol and progesterone dose-dependently enhanced the contractile response to trypsin. A maximal enhancement was obtained at 25 and 40 mg kg weight -1 day -1 for 17β-estradiol and progesterone, respectively. The extent of the enhancement of the trypsin-induced contraction seen in the sex hormone-treated rats in the present study was comparable to that reported in the pregnant rats. However, the contractile response to thrombin and PAR1/PAR2-AP, SFLLRNP was not enhanced either by progesterone or 17β-estradiol. PAR2-AP and PAR4-AP failed to induce contraction under any conditions. PAR1 mRNA was scarcely detected in the control myometrium by an RT-PCR analysis, while it slightly increased only in the progesterone-treated rats. Neither PAR2 nor PAR4 mRNA was detected. We thus conclude that the responsiveness to trypsin, but not thrombin, is controlled by sex hormones. A novel type of receptor, other than PAR1, PAR2 or PAR4, is suggested to mediate the trypsin-induced contraction as in the case of the pregnant rat myometrium.

AB - We have previously reported that the contractile response to thrombin and trypsin was enhanced in the pregnant rat myometrium. We herein determined whether or not sex hormones contribute to this enhancement and the expression of protease-activated receptors (PARs). The nonpregnant rats received daily injections of either 17β-estradiol or progesterone, and then the contractile response of the myometrium was examined ex vivo. Treatment with either 17β-estradiol or progesterone had almost no significant enhancing effect on the high K +- or oxytocin-induced contraction. On the other hand, both 17β-estradiol and progesterone dose-dependently enhanced the contractile response to trypsin. A maximal enhancement was obtained at 25 and 40 mg kg weight -1 day -1 for 17β-estradiol and progesterone, respectively. The extent of the enhancement of the trypsin-induced contraction seen in the sex hormone-treated rats in the present study was comparable to that reported in the pregnant rats. However, the contractile response to thrombin and PAR1/PAR2-AP, SFLLRNP was not enhanced either by progesterone or 17β-estradiol. PAR2-AP and PAR4-AP failed to induce contraction under any conditions. PAR1 mRNA was scarcely detected in the control myometrium by an RT-PCR analysis, while it slightly increased only in the progesterone-treated rats. Neither PAR2 nor PAR4 mRNA was detected. We thus conclude that the responsiveness to trypsin, but not thrombin, is controlled by sex hormones. A novel type of receptor, other than PAR1, PAR2 or PAR4, is suggested to mediate the trypsin-induced contraction as in the case of the pregnant rat myometrium.

UR - http://www.scopus.com/inward/record.url?scp=27144501590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27144501590&partnerID=8YFLogxK

U2 - 10.1038/sj.bjp.0706345

DO - 10.1038/sj.bjp.0706345

M3 - Article

C2 - 16056237

AN - SCOPUS:27144501590

VL - 146

SP - 425

EP - 434

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 3

ER -